1. Home
  2. Africa

Free AIDS drug programme spurned

A strong political will is needed to effectively tackle the HIV/AIDS epidemic in Africa, German pharmaceutical company Boehringer-Ingelheim has said.

In a recent statement, Boehringer-Ingelheim said only two African countries had accepted its offer of the free supply of nevirapine for the prevention of mother-to-child transmission of HIV.

Company chairman, Rolf Krebs, said: "We are not at all satisfied with how the programme is running."

He said heavy customs charges, poor logistics and a lack of the necessary health care infrastructure were some of the reasons why the rest of the continent had not taken part in the programme.

Krebs said steps were being taken to simplify the application process, following international criticism of the complicated bureaucracy of the programme.


This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join